Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

EPOR anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement EPOR dans FACS et cELISA. Il présente une réactivité envers Humain et a été mentionné dans 2+ publications.
N° du produit ABIN1720915

Aperçu rapide pour EPOR anticorps (ABIN1720915)

Antigène

EPOR (Erythropoietin Receptor (EPOR))

Reactivité

  • 113
  • 45
  • 45
  • 8
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Humain

Hôte

  • 99
  • 22
  • 5
  • 1
Souris

Clonalité

  • 106
  • 20
  • 1
Monoclonal

Conjugué

  • 71
  • 13
  • 7
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp EPOR est non-conjugé

Application

  • 97
  • 41
  • 32
  • 24
  • 22
  • 20
  • 19
  • 14
  • 14
  • 5
  • 5
  • 5
  • 4
  • 2
  • 2
  • 1
Flow Cytometry (FACS), Cell-ELISA (cELISA)

Clone

VP-2E8
  • Specificité

    Anti-human Epo-R

    Attributs du produit

    Selection: Based on recognition of the complete native protein expressed on transfected mammalian cells

    Purification

    Protein G

    Immunogène

    genetic immunisation with cDNA encoding the ECD of human Epo-R

    Isotype

    IgG1
  • Indications d'application

    Flow cytometry: 1.2 µg/10^6 cells
    ELISA: 1:200 - 1:400
    CELISA: 1:200 - 1:400
    For each application a titration should be performed to determine the optimal concentration.

    Commentaires

    Synonyms: Erythropoietin receptor

    Restrictions

    For Research Use only
  • Buffer

    PBS, pH 7.2

    Conseil sur la manipulation

    Avoid repeated freezing and thawing.

    Stock

    4 °C

    Stockage commentaire

    short term: 2 °C - 8 °C, long term: -20 °C
  • Maxwell, Melendez-Rodríguez, Matchett, Aragones, Ben-Califa, Jaekel, Hengst, Lindner, Bernardini, Brockmeier, Fandrey, Grunert, Oster, Mittelman, El-Tanani, Thiersch, Schneider Gasser, Gassmann et al.: "Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation. ..." dans: British journal of haematology, Vol. 168, Issue 3, pp. 429-42, (2015) (PubMed).

    Hedley, Allan, Xenocostas: "The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 17, Issue 20, pp. 6373-80, (2011) (PubMed).

  • Antigène

    EPOR (Erythropoietin Receptor (EPOR))

    Autre désignation

    EPOR

    Sujet

    Erythropoietin receptor (Epo-R) belongs to the cytokine receptor family and is a 507 amino acid type I transmembrane protein. EpoR pre-exists as dimers which changes the homodimerized state after binding of its 34 kDa ligand erythropoietin (Epo). Erythropoietin is the primary regulator of erythropoiesis, and promotes the survival, proliferation, and differentiation of erythroid progenitor cells. Both, Epo and Epo-R are essential for the production of red blood cells due to Epo exerts its function through the Epo receptor. The Epo-R is also expressed in many organs outside the bone marrow, suggesting that Epo is a pleiotropic anti-apoptotic factor. Signaling pathways have been shown to influence numerous cellular functions in normal and tumor cells, including proliferation, apoptosis, and drug resistance.

    UniProt

    P19235

    Pathways

    Signalistation JAK/STAT
Vous êtes ici:
Chat with us!